UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013228
Receipt number R000015438
Scientific Title Pain strength and saliva alpha amylase of the pain patient, other pain-related relations with the factor
Date of disclosure of the study information 2014/02/24
Last modified on 2014/02/23 11:57:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pain strength and saliva alpha amylase of the pain patient, other pain-related relations with the factor

Acronym

Pain strength and saliva alpha amylase of the pain patient, other pain-related relations with the factor

Scientific Title

Pain strength and saliva alpha amylase of the pain patient, other pain-related relations with the factor

Scientific Title:Acronym

Pain strength and saliva alpha amylase of the pain patient, other pain-related relations with the factor

Region

Japan


Condition

Condition

Patients having a pain

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose investigate a pain and relations of alpha amylase for patients having a pain.

Basic objectives2

Others

Basic objectives -Others

As well as a pain, We check a state of the stress checked by question vote Stress Response Scale-18(SRS-18), state of feeling such as strain, dejection, anger, vigor, fatigue(Profile of mode state: POMS), the pain Catastrophizing Scale(PCS) and the quality of life (EuroQual-5Demention).

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

Visual Analogue Scale
Saliva alpha amylase

Key secondary outcomes

Stress Response Scale-18(SRS-18)
simplified Profile of mode state(simplified POMS)
Pain Catastrophizing Scale(PCS)
EuroQuol-5Dimention Questionnaire(EQ5-D)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

We measure saliva alpha amylase by one point

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients having a pain

Key exclusion criteria

patients who cannot fill out a question vote

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Rie Hasegawa

Organization

Juntendo University School of Medicine

Division name

Department of Anesthesiology and Pain Medicine

Zip code


Address

3-1-3 hongou bunkyou-ku Tokyou 113-8431 Japan

TEL

090-8350-5708

Email

rhase@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Rie Hasegawa

Organization

Juntendo University School of Medicine

Division name

Department of Anesthesiology and Pain Medicine

Zip code


Address

3-1-3 hongou bunkyou-ku Tokyou 113-8431 Japan

TEL

090-8350-5708

Homepage URL


Email

rhase@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University School of Medicine, Department of Anesthesiology and Pain Medicine

Institute

Department

Personal name



Funding Source

Organization

Juntendo University School of Medicine, Department of Anesthesiology and Pain Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 02 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2014 Year 02 Month 23 Day

Date of IRB


Anticipated trial start date

2014 Year 02 Month 24 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 02 Month 23 Day

Last modified on

2014 Year 02 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015438


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name